This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Sickle Cell Disease, Sickle Cell Anemia, Sickle Cell Disorders, Hemoglobin S Disease or Sickling Disorder Due to Hemoglobin S
and you are
between 12 and 60
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to evaluate the effects of HQK-1001 on Hb F in subjects with sickle cell disease.

Provided treatments

  • Drug: HQK-1001
  • Drug: Placebo
Tris trial is registered with FDA with number: NCT01601340. The sponsor of the trial is HemaQuest Pharmaceuticals Inc. and it is looking for 77 volunteers for the current phase.
Official trial title:
A Randomized, Placebo-controlled, Phase 2 Study of HQK-1001 in Sickle Cell Disease